Literature DB >> 9893115

Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.

T Takemura1, S Hino, Y Murata, H Yanagida, M Okada, K Yoshioka, R C Harris.   

Abstract

BACKGROUND: Transfection of renal epithelial cells (NRK 52E) with membrane-associated heparin-binding epidermal growth factor-like growth factor (proHB-EGF) increased renal epithelial cell survival by promoting cell-cell and cell-extracellular matrix interactions. ProHB-EGF has been shown to form a complex in the plasma membrane with the tetraspanin CD9, an interaction that significantly increases the effectiveness of proHB-EGF as a juxtacrine mitogenic agent.
METHODS: We examined whether the coexpression of proHB-EGF and CD9 would increase renal epithelial cell survival. CD9 was stably transfected into NRK 52E cells, either alone (NRKCD9) or together with proHB-EGF (NRKboth).
RESULTS: Juxtacrine mitogenic activity of NRKCD9 was no different than in cells transfected with vector alone (NRKvector), but was increased by NRKboth; juxtacrine mitogenic activity by NRKboth was twofold greater than when proHB-EGF was transfected alone (NRKproHB-EGF). When grown in 10% fetal calf serum, growth rates were similar among all transfectants. However, in 1% fetal calf serum, NRKproHB-EGF grew 50% faster than NRKvector or NRKCD9, and NRKboth grew 20% to 50% faster than NRKproHB-EGF at one, two, and three days of culture. NRKproHB-EGF attachment to plastic substratum at one, two, and three hours was 250% greater than that of NRKvector, and NRKboth was 20% to 30% greater than that of NRKproHB-EGF. Coating plates with either poly 2-hydroxyethyl methacrylate or the GRGDTP peptide prevented normal cell-extracellular matrix attachment, and NRKvector or NRKCD9 failed to attach or form cell-cell attachments. NRKproHB-EGF exhibited 300% and NRKboth exhibited 600% greater cell viability under these conditions. Expression of type I and type III collagen mRNA was enhanced similarly in NRKproHB-EGF and NRKboth, but the expression of beta1 integrin was up-regulated only in NRKboth.
CONCLUSIONS: Coexpression of proHB-EGF and CD9 may render the renal epithelial cells more resistant to disruption of cell-cell and cell-matrix interactions and could accelerate the re-establishment of these attachments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9893115     DOI: 10.1046/j.1523-1755.1999.00259.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Authors:  Jianying Dong; Lee K Opresko; William Chrisler; Galya Orr; Ryan D Quesenberry; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

2.  Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats.

Authors:  Mitsuru Okada; Hidehiko Yanagida; Hiroaki Kuwajima; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

3.  Kidney Diseases Enhance Expression of Tetraspanin-8: A Possible Protective Effect against Tubular Injury.

Authors:  Takashi Hirukawa; Qiong Wu; Kaichiro Sawada; Taiji Matsusaka; Sanae Saka; Akira Oka; Nobuhito Hirawa; Satoshi Umemura; Takatoshi Kakuta; Masayuki Endoh; Hidetoshi Inoko; Iekuni Ichikawa; Masafumi Fukagawa
Journal:  Nephron Extra       Date:  2014-04-30

4.  Mechanisms of Hypoxia-Induced Pulmonary Arterial Stiffening in Mice Revealed by a Functional Genetics Assay of Structural, Functional, and Transcriptomic Data.

Authors:  Edward P Manning; Abhay B Ramachandra; Jonas C Schupp; Cristina Cavinato; Micha Sam Brickman Raredon; Thomas Bärnthaler; Carlos Cosme; Inderjit Singh; George Tellides; Naftali Kaminski; Jay D Humphrey
Journal:  Front Physiol       Date:  2021-09-14       Impact factor: 4.566

5.  Adhesion proteins--an impact on skeletal myoblast differentiation.

Authors:  Marta Przewoźniak; Iwona Czaplicka; Areta M Czerwińska; Agnieszka Markowska-Zagrajek; Jerzy Moraczewski; Władysława Stremińska; Katarzyna Jańczyk-Ilach; Maria A Ciemerych; Edyta Brzoska
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

6.  Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.

Authors:  Shuji Sato; Hiroko Kamada; Takahiro Watanabe; Isamu Tsuji; Jinhong Fan
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.